Apolipoprotein E polymorphism in cerebrovascular disease

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Apolipoprotein E (apo E) is a key protein in lipid metabolism and has been implicated in various neurological conditions.
• The apo E genotype is known to influence the risk of Alzheimer's disease and cardiovascular diseases.
• Its role in the pathogenesis and prognosis of acute stroke subtypes requires further investigation.

Purpose of the Study:

• To investigate the association between apo E genotype and the risk of acute cerebral infarction (CI) and primary intracerebral hemorrhage (PICH).
• To examine the relationship between apo E genotype and mortality following acute stroke.

Main Methods:

• A study involving 592 acute stroke cases and 289 healthy controls.
• Stroke type (CI and PICH) determined by cranial computed tomography.
• Cerebral infarction subtypes classified using the Oxfordshire Community Stroke Project Classification (OCSP).
• Apo E genotyping performed using polymerase chain reaction.

Main Results:

• No significant difference in apo E genotype frequencies was observed between stroke cases and healthy controls.
• Apo E genotype was not associated with the pathological type of stroke (CI vs. PICH).
• No association was found between apo E genotype and specific OCSP subtypes of cerebral infarction.
• Apo E genotype did not correlate with all-cause mortality following stroke, with a median follow-up of 851 days.

Conclusions:

• The apolipoprotein E polymorphism is not related to the pathogenesis of cerebral infarction or primary intracerebral hemorrhage in this population.
• Apo E genotype does not appear to be a significant predictor of mortality after acute stroke.